Methods | Double‐blind randomised placebo‐controlled trial. The trial was conducted in Denmark. |
|
Participants | 28 healthy women with early menopause (6 months to 3 years earlier). Overweight was not an exclusion criterion. | |
Interventions | Intervention group:2000 mg calcium per day (14 participants). Control group: identical‐looking placebo tablets (14 participants). Trial duration: 1 year. |
|
Outcomes | Blood pressure. BP was measured by mercury manometer after 10 min of supine rest | |
Notes | Tablets were provided by Sandoz | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Participants were allocated into 2 groups according to random sampling numbers |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double‐blind, placebo‐controlled trial. Participants received identical‐looking tablets |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants were evaluated at the end of the study. |
Selective reporting (reporting bias) | Low risk | The primary outcome was reported. |
Other bias | High risk | Placebo participants had higher initial weight and lower systolic blood pressure. |